Echarte MJC, Alfonso RE, Hechavarría PS, Calderín PR, Martínez CA, Borges MYR, Martínez VO, Echarte MJC

Language: Spanish
References: 13
Page: 204-208
PDF size: 303.84 Kb.

ABSTRACT

Severe aortic stenosis represents a major health problem. Its degenerative origin is the most common cause in adult patients. The atherosclerotic process begins in the aortic annulus and invades the sinuses of Valsalva and commissures, restrict-ing valvular opening. The most common treatment at present, in selected patients, is the transcatheter aortic valve implantation; but not all health systems can afford this possibility. This article presents the case of a 94-year-old man with a history of chronic ischemic heart disease plus this valve disease, who underwent right coro-nary angioplasty (due to a 70% de novo ulcerated lesion in the middle segment) and balloon aortic valvuloplasty.

REFERENCES

1. Akahori H, Tsujino T, Masuyama T, Ishihara M. Mechanisms of aortic stenosis. J Cardiol. 2018; 71(3):215-20. [DOI]

2. de Oliveira Sá MP, Cavalcanti LR, Perazzo ÁM, Gomes RA, Clavel MA, Pibarot P, et al. Calcific aortic valve stenosis and atherosclerotic calcifica-tion. Curr Atheroscler Rep [Internet]. 2020 [citado 26 Jun 2021];22(2):2. [DOI]

3. Díez-Villanueva P, Arizá-Solé A, Vidán MT, Bo-nanad C, Formiga F, Sanchis J, et al. Recomenda-ciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valo-ración de la fragilidad en el anciano con cardio-patía. Rev Esp Cardiol. 2019;72(1):63-71. [DOI]

4. Khanji MY, Ricci F, Galusko V, Sekar B, Chahal CAA, Ceriello L, Gallina S, Kennon S, Awad WI, Ionescu A. Management of aortic stenosis: A sys-tematic review of clinical practice guidelines and recommendations. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):340-53. [DOI]

5. Pepe M, Larosa C, Rosa I, Biondi-Zoccai G, Nesto-la PL, Di Cillo O, et al. Degenerative severe aortic stenosis and concomitant coronary artery dis-ease: What is changing in the era of the "Trans-catheter Revolution"? Curr Atheroscler Rep [In-ternet]. 2020 [citado 30 Jun 2021];22(5):17. Dispo-nible en: https://doi. org/10. 1007/s11883-020-0835-1

6. Boskovski MT, Gleason TG. Current therapeutic options in aortic stenosis. Circ Res. 2021;128(9): 1398-417. [DOI]

7. Lax J, Stutzbach P, Beck M, Martín Perea F, Cian-ciulli T, Grancelli H, et al. Consenso de valvulo-patías. Rev Argent Cardiol. 2015;83(Supl 2):1-104.

8. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the Eu-ropean Society of Cardiology (ESC) and the Eu-ropean Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022;43(7):561-632. [DOI]

9. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2020.

10. Riquenes Cutió O, Domínguez Cruz AM, Infante Vigil-Escalera A. Cuba, ¿una zona azul? Juventud Rebelde. 30 May 2017. Disponible en:https://www. juventudrebelde. cu/cuba/2017-05-30/cuba-una-zona-azul

11. Konishi A, Iwasaki M, Omori T, Shinke T. The ef-fect of multiple-inflation balloon aortic valvulo-plasty. Heart Vessels. 2020;35(11):1557-62. [DOI]

12. Williams T, Hildick-Smith DJ. Balloon aortic val-vuloplasty: indications, patient eligibility, tech-nique and contemporary outcomes. Heart. 2020; 106(14):1102-10. [DOI]

13. Alkhouli M, Zack CJ, Sarraf M, Bashir R, Nishimu-ra RA, Eleid MF, et al. Morbidity and mortality as-sociated with balloon aortic valvuloplasty: A na-tional perspective. Circ Cardiovasc Interv [Inter-net]. 2017 [citado 4 Jul 2021];10(5):e004481. Dis-ponible en:https://doi. org/10. 1161/circinterventions. 116. 004481